| Category | BioTech |
| Employees | |
| Description | drug developer in stealth mode |
| TOTAL | $7M |
| FUNDING TOTAL | $7M |
| Series A, 1/09 ARCH Venture Partners Wellcome Trust | $7M |
Qwell’s goal is to develop a new family of small-molecule drugs, derived from a plant source, that have a potent ability to fight tumors and excess inflammation of skin cells.
